Abstract:Aims It is increasingly appreciated that coordinated regulation of angiogenesis and osteogenesis is needed for bone formation. How this regulation is achieved during peri-implant bone healing, such as osseointegration, is largely unclear. This study examined the relationship between angiogenesis and osteogenesis in a unique model of osseointegration of a mouse tibial implant by pharmacologically blocking the vascular endothelial growth factor (VEGF) pathway. Materials and Methods An implant was inserted into the right tibia of 16-week-old female C57BL/6 mice (n = 38). Mice received anti-VEGF receptor-1 (VEGFR-1) antibody (25 mg/kg) and VEGF receptor-2 (VEGFR-2) antibody (25 mg/kg; n = 19) or an isotype control antibody (n = 19). Flow cytometric (n = 4/group) and immunofluorescent (n = 3/group) analyses were performed at two weeks post-implantation to detect the distribution and density of CD31hiEMCNhi endothelium. RNA sequencing analysis was performed using sorted CD31hiEMCNhi endothelial cells (n = 2/group). Osteoblast lineage cells expressing osterix (OSX) and osteopontin (OPN) were also detected with immunofluorescence. Mechanical pull-out testing (n = 12/group) was used at four weeks post-implantation to determine the strength of the bone-implant interface. After pull-out testing, the tissue attached to the implant surface was harvested. Whole mount immunofluorescent staining of OSX and OPN was performed to determine the amount of osteoblast lineage cells. Results Flow cytometry revealed that anti-VEGFR treatment decreased CD31hiEMCNhi vascular endothelium in the peri-implant bone versus controls at two weeks post-implantation. This was confirmed by the decrease of CD31 and endomucin (EMCN) double-positive cells detected with immunofluorescence. In addition, treated mice had more OPN-positive cells in both peri-implant bone and tissue on the implant surface at two weeks and four weeks, respectively. More OSX-positive cells were present in peri-implant bone at two weeks. More importantly, anti-VEGFR treatment decreased the maximum load of pull-out testing compared with the control. Conclusion VEGF pathway controls the coupling of angiogenesis and osteogenesis in orthopaedic implant osseointegration by affecting the formation of CD31hiEMCNhi endothelium. Cite this article: Bone Joint J 2019;101-B(7 Supple C):108–114.

Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair.

Osteogenic Role of Vascular Endothelial Growth Factor in Bone Regeneration.

Distinct VEGF functions during bone development and homeostasis

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

Soluble VEGFR1 reverses BMP2 inhibition of intramembranous ossification during healing of cortical bone defects

Effect of Vascular Endothelial Cell Growth Factor on Repair of Bone Defect with Cortical Bone Allograft

Osteoporosis Influences Osteogenic but Not Angiogenic Response During Bone Defect Healing in a Rat Model

Osteoblast-derived EGFL6 couples angiogenesis to osteogenesis during bone repair

Mesenchymal Stromal Cells Regulate the Cell Mobility and the Immune Response During Osteogenesis Through Secretion of Vascular Endothelial Growth Factor A

Effects of Vascular Endothelial Growth Factor on Osteoblasts Around Dental Implants in Vitro and in Vivo

Effects of Vascular Endothelial Growth Factor for Repairing Bone Defect

Influence of vascular endothelial growth factor on osteogenesis of coral bone substitute

Mesenchymal VEGFA induces aberrant differentiation in heterotopic ossification

Vascular Derived ECM Improves Therapeutic Index of BMP-2 and Drives Vascularized Bone Regeneration.

Complementary Interplay Between Matrix Metalloproteinase-9, Vascular Endothelial Growth Factor and Osteoclast Function Drives Endochondral Bone Formation

Chondrocytes Promote Vascularization in Fracture Healing Through a FOXO1‐Dependent Mechanism

Vascular endothelial growth factor pathway promotes osseointegration and CD31<sup>hi</sup>EMCN<sup>hi</sup> endothelium expansion in a mouse tibial implant model

Activation of the Hypoxia-Inducible Factor-1 Alpha Pathway Accelerates Bone Regeneration

BDNF regulates the expression and secretion of VEGF from osteoblasts via the TrkB/ERK1/2 signaling pathway during fracture healing.

Bmp2 and Vegf Promote Angiogenesis but Retard Terminal Differentiation of Osteoblasts in Bone Regeneration by Up-Regulating Id1

Vascular Endothelial Growth Factor Pathway Promotes Osseointegration and CD31(hi)EMCN(hi) Endothelium Expansion in a Mouse Tibial Implant Model AN ANIMAL STUDY